These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 9572491)

  • 41. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice.
    Zhang H; Kuang SQ; Liao L; Zhou S; Xu J
    Cancer Res; 2004 Oct; 64(19):7169-77. PubMed ID: 15466215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
    Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
    Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of apoptosis during mammary involution by the p53 tumor suppressor gene.
    Jerry DJ; Dickinson ES; Roberts AL; Said TK
    J Dairy Sci; 2002 May; 85(5):1103-10. PubMed ID: 12086044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
    Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
    Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.
    DuHadaway JB; Du W; Donover S; Baker J; Liu AX; Sharp DM; Muller AJ; Prendergast GC
    Oncogene; 2003 Jun; 22(23):3578-88. PubMed ID: 12789266
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of the level of the oncoprotein p53 in non-transformed and transformed cells.
    Reihsaus E; Kohler M; Kraiss S; Oren M; Montenarh M
    Oncogene; 1990 Jan; 5(1):137-45. PubMed ID: 2157179
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SV40 T/t-antigens sensitize mammary gland epithelial cells to oxidative stress and apoptosis.
    Kohlhoff S; Ziechmann C; Gottlob K; Graessmann M
    Free Radic Biol Med; 2000 Sep; 29(6):497-506. PubMed ID: 11025193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immortalization of BALB/c mouse embryo fibroblasts alters SV40 large T-antigen interactions with the tumor suppressor p53 and results in a reduced SV40 transformation-efficiency.
    Tiemann F; Deppert W
    Oncogene; 1994 Jul; 9(7):1907-15. PubMed ID: 8208537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T1, an immunoglobulin superfamily member, is expressed in H-ras-dependent epithelial tumours of mammary cells.
    Rössler U; Andres AC; Reichmann E; Schmahl W; Werenskiold AK
    Oncogene; 1993 Mar; 8(3):609-17. PubMed ID: 8437844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth.
    Bocchetta M; Eliasz S; De Marco MA; Rudzinski J; Zhang L; Carbone M
    Cancer Res; 2008 Feb; 68(4):1022-9. PubMed ID: 18281476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of a novel p53 mutation in JCV-induced mouse medulloblastoma.
    Krynska B; Del Valle L; Gordon J; Otte J; Croul S; Khalili K
    Virology; 2000 Aug; 274(1):65-74. PubMed ID: 10936089
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.
    Yoshidome K; Shibata MA; Couldrey C; Korach KS; Green JE
    Cancer Res; 2000 Dec; 60(24):6901-10. PubMed ID: 11156389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impaired CK1 delta activity attenuates SV40-induced cellular transformation in vitro and mouse mammary carcinogenesis in vivo.
    Hirner H; Günes C; Bischof J; Wolff S; Grothey A; Kühl M; Oswald F; Wegwitz F; Bösl MR; Trauzold A; Henne-Bruns D; Peifer C; Leithäuser F; Deppert W; Knippschild U
    PLoS One; 2012; 7(1):e29709. PubMed ID: 22235331
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antisense to SV40 early gene region induces growth arrest and apoptosis in T-antigen-positive human pleural mesothelioma cells.
    Waheed I; Guo ZS; Chen GA; Weiser TS; Nguyen DM; Schrump DS
    Cancer Res; 1999 Dec; 59(24):6068-73. PubMed ID: 10626792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apoptosis is induced at nonpermissive temperature by a transient increase in p53 in cell lines immortalized with temperature-sensitive SV40 large T-antigen gene.
    Yanai N; Obinata M
    Exp Cell Res; 1994 Apr; 211(2):296-300. PubMed ID: 8143776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mammary development and tumorigenesis in mice expressing a truncated human Notch4/Int3 intracellular domain (h-Int3sh).
    Raafat A; Bargo S; Anver MR; Callahan R
    Oncogene; 2004 Dec; 23(58):9401-7. PubMed ID: 15531924
    [TBL] [Abstract][Full Text] [Related]  

  • 57. p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinoma.
    Shibata MA; Maroulakou IG; Jorcyk CL; Gold LG; Ward JM; Green JE
    Cancer Res; 1996 Jul; 56(13):2998-3003. PubMed ID: 8674054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. p53 mutants with changes in conserved region II: three classes with differing antibody reactivity, SV40 T antigen binding and ability to inhibit transformation of rat cells.
    Schmieg FI; Simmons DT
    Oncogene; 1993 Aug; 8(8):2043-50. PubMed ID: 8393158
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulatory function of whey acidic protein in the proliferation of mouse mammary epithelial cells in vivo and in vitro.
    Nukumi N; Ikeda K; Osawa M; Iwamori T; Naito K; Tojo H
    Dev Biol; 2004 Oct; 274(1):31-44. PubMed ID: 15355786
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
    Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
    Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.